Open an account

CareDx

CDNA · NASDAQ

$69.20+$2.12 (+3.16%)TodayMarket closed ·
Prev close $67.08

About CDNA

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. The company is headquartered in Brisbane California, California and currently employs 761 full-time employees. The company went IPO on 2014-07-17. The firm is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. The company offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. The company also offers a diverse portfolio of digital solutions to transplant centers.

Employees
761
Headquarters
Brisbane California, California
Listed
Jul 17, 2014
Sector
Health Care
Industry
Biotechnology
Website
caredx.com

CDNA key statistics

Market cap
3.58B
Price-earnings ratio
32.41
Dividend yield
—
Average volume
1.57M
Volume
1.56M
Open price
$67.20
High today
$70.81
Low today
$65.89
52 Week high
$72.51
52 Week low
$14.03

CareDx (CDNA) at a glance

As of Oct 20, 2026, CareDx (CDNA) shares are priced at $69.20, giving the company a market cap of 3.58B and a price-to-earnings ratio of 32.41.

Today the stock has traded between $65.89 and $70.81. The current price is 5.0% above the day's low and 2.3% below its high.

Volume so far is 1.56M shares, in line with the average of 1.57M shares a day.

Over the past year CareDx has ranged from $14.03 to $72.51, and now sits 94% of the way up that range.

CareDx met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.37 per share against an estimate of $0.2375.

The average analyst price target is $60.01, 13.3% below the current price, from 4 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

50%of 4 analyst ratings say Buy
  • Buy50.0%
  • Hold50.0%
  • Sell0.0%
Price target · 8 analystsAvg $60.01
Low
$46.46
Now
$69.20
High
$77.70

CDNA earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 274.2% on average.

  1. Q3 FY24: reported $0.14 per share against an estimate of $0.0102
  2. Q4 FY24: reported $0.18 per share against an estimate of $0.1311
  3. Q1 FY25: reported $0.09 per share against an estimate of $0.0662
  4. Q2 FY25: reported $0.10 per share against an estimate of $0.1221
  5. Q3 FY25: reported $0.28 per share against an estimate of $0.1445
  6. Q4 FY25: reported $0.12 per share against an estimate of $0.2439
  7. Q1 FY26: reported $0.34 per share against an estimate of $0.1362
  8. Q2 FY26: reported $0.37 per share against an estimate of $0.2375

CDNA news

  • Press releaseBusiness Wire

    CareDx to Report Third Quarter 2026 Financial Results on October 29, 2026

  • Chandrima Sanyal

    Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

  • 10 Health Care Stocks With Whale Alerts In Today’s Session

  • Vandana Singh

    Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently

  • Press releaseBusiness Wire

    CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseBusiness Wire

    CareDx Announces Second Quarter 2026 Financial Results

  • Vandana Singh

    Why Is CareDx Stock Skyrocketing Thursday?

Similar companies

Companies in the same industry as CareDx

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.